HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cosmetics That ‘Do Something’ A Regulatory Compliance Challenge

This article was originally published in The Rose Sheet

Executive Summary

Food and drug attorney Katherine Giannamore speaks to the challenges cosmetic firms face in marketing their offerings competitively – as products that “do something” – without violating FDA’s definition of a cosmetic. While companies may instinctively want to push the envelope, the repercussions of a warning letter should not be taken lightly, she said, emphasizing the importance of regulatory risk assessment.

You may also be interested in...



Nutricosmetics Pose Intriguing Possibilities For Brands That Hit Wall With Skin-Care Claims

Statements about collagen production, maintaining cellular integrity, addressing age spots, even shrinking wrinkles and treating noncystic acne – all are viable structure/function claims for nutricosmetics, assuming there's evidence to back them up. The Rose Sheet discusses the growing opportunity with regulatory and legal experts and provides an overview of the market at present.

J&J Skin Care Continues Apace With ‘Rapid’ Products, ‘1 Week’ Claims

Regulatory and legal challenges have not held back J&J/Neutrogena’s Rapid Wrinkle Repair business, which has been joined by a Rapid Tone Repair line and Rapid Clear acne treatments. Meanwhile, new Aveeno Absolutely Ageless products similarly provide results in just one week, the company says.

FDA Warning Letter Recipients: Where Are Their Claims Now?

A key component of FDA’s enforcement strategy in the cosmetics space is monitoring companies’ websites for overreaching product claims and issuing warning letters accordingly. Examination of past offenders’ current sites and updated claims offers potential visibility into language the agency will and will not tolerate when it comes to promoting skin-care benefits.

Related Content

UsernamePublicRestriction

Register

LL1134420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel